MICA and neoplasm: This observation had previously been made Groh et al. in an in vitro assay: by loading dendritic cells with anti-MICA opsonized breast, melanoma, or ovarian tumor lines, tumor antigen cross-presentation was promoted and thereby primed antitumor effector CD4 and CD8 T cell responses (84).